THE JOURNAL OF EXPERIMENTAL MEDICINE -VOLUME 142, 1975 1403 times in cold medium, and clumps were removed by letting the cell suspension settle for 5 min. Viability of cells in the supernatant fluid was determined by trypan blue dye exclusion. Thoracic duct lymphocytes (TDL) were collected as previously described (5). T cells activated to H-2-determinants were prepared by injecting 2 x 10 8 CBA thymus cells intravenously into Xirradiated (800R) (CBA/J x C57BL)F, hybrid mice . The activated cells were then obtained 4-6 days later either from the spleen (ATC-spleen) or from thoracic duct lymph (T .TDL) (5) . In some experiments, lymph node cells were used to prepare the ATC. ATC-spleen (SJL/J) were prepared by injection of 5 x 108 nylon wool column purified SJL/J lymph node T cells into X-irradiated (800 R) (SJIJJ x C57BL)F, hybrid mice . To obtain T cells activated by M-locus determinants, C3H/J thymus cells were transferred into irradiated CBA/J mice .
Dead cells were removed from ATC-spleen by the method of v. Boehmer et al . (6) , and lymphocytes were isolated over a Ficoll gradient (recovery of viable ATC-spleen was 30-40%). Suspensions of thymus cells were depleted of B cells by filtration through Sephadex G-100 columns conjugated with rabbit antimouse Ig antibody (7) . In other experiments lymph node cells were freed of B cells by passage through nylon wool columns (8) . The relative proportions of T and B cells in each population was determined by indirect immunofluorescence and cytotoxicity with anti-Thy 1 .2 (theta C3H) serum. These methods have been described elsewhere (9, 10) .
For preparation of cortisone resistant thymocytes, (CRT) mice were injected with 0.125 mg hydrocortisoneacetate/g and the thymus removed 2 days later. Normal thymocytes or CRT were stimulated by concanavalin A (Con A) or phytohemagglutinin (PHA). Stimulation of cultured cells wasmeasured by incorporation of [3H]thymidine as described elsewhere (11) . 5 gg Con A and 10 Ag PHA were optimal for stimulation. Stimulation indices were : normal thymus cells Con A 196, PHA 5; CRT Con A 230, PHA 30 .
Antisera . Anti-Thy 1.2 serum was raised by the method of Raff (12) . Anti-C57, anti-CBA, and anti-SJL sera were produced in CBA, C57, and C3H, respectively, as described previously (13) . These sera were specific for their targets. The preparation and specificity of ATH anti-ATL serum has extensively been described elsewhere (14) .
Fc-and C-Receptors . A rosette test with relatively nonagglutinable bovine erythrocytes (ox (bovine) red blood cells, ORBC) as indicator cells was used to detect FcR (EA rosettes) and Creceptors (EAC rosettes) .
Rabbit (gift from Dr . M. Ferrarini, Genova) as well as mouse (DBA) anti-ORBC sera were prepared . Rabbit-anti-ORBC serum 224 (rich in IgG), rabbit-anti-ORBC (IgM) (purified IgM fraction in a dilution of 1 :50 in complement fixation test diluent [CFTD]), and Balb/cM anti-ORBC serum (Sephadex G-200 column purified IgM) were used for sensitization of indicator cells. Neither Balb/cM anti-ORBC IgM nor DBA anti-ORBC serum showed any agglutination of ORBC, although the hemolytic titer (with guinea pig complement [GPC1 diluted 1:10) was 1:64 for Balb/cM anti-ORBC (IgM) and 1 :1,024 for DBA anti-ORBC serum. For sensitization of ORBC, Balb/cM anti-ORBC IgM was diluted 1:2 or 1 :4 in CFTD, and DBA anti-ORBC serum was diluted 1:5 in phosphate-buffered saline (PBS).
Preparation ofSensitized Red Cells for EA-Rosettes . Equal volumes of a 2% ORBC suspension in PBS and either rabbit or mouse anti-ORBC antisera (serum 224 or DBA anti-ORBC antiserum), at the dilutions indicated above, were incubated for 30 min at room temperature . After incubation, the red cells were washed twice in PBS and resuspended to 0.5% (vol/vol) in TC Medium 199 plus 10% FCS (modified from [151) .
Preparation of Sensitized Red Cells for EAC-Rosettes . ORBC, thoroughly washed in CFTD (16), were sensitized as above with the indicated dilutions of either rabbit anti-ORBC IgM or Balb/cM anti-ORBC IgM, and washed twice in CFTD . The EA complex was then treated with mouse complement (AKR serum previously absorbed at 4°C for 30 min with an equal volume of washed, packed ORBC and diluted 1:2 in CFTD), washed twice in CFTD, and adjusted to a concentration of 0.5% in Medium 199 plus 10% FCS (modified from [171) .
Rosette Test . 20 pl of the 0.5% suspension of sensitized red cells were added to 20 Wl of the test cell suspension (3 x 108 cells/ml) in plastic tubes (Luckhan Ltd., LP2) . Tubes were centrifuged at 400g for 5 min at 4°C. EAC-rosettes were immediately resuspended by gentle pipetting with a Pasteur pipette; EA-rosettes were resuspended after 30 min at 0°C . A drop of suspension was placed on a siliconized slide and overlayed with a siliconized coverslip. The edges of the coverslip were sealed with wax. Each test was performed in triplicate and the percentage of rosettes determined (a minimum of 300 cells per preparation was counted) . A cell with more than four adherent erythrocytes was regarded as a rosette.
Each test included erythrocyte rosettes (E-rosettes) as simultaneous controls for EA(IgG)-rosettes and EA(IgM)-rosettes as controls for EAC-rosettes . Fluorochromasia with fluorescein diacetate (FDA) (18) was used to assess the percentage of live cells forming rosettes .
Inhibition of Fc-Rosettes . Purified myeloma proteins (gifts from Drs. G. Torrigiani, R. Pink, and F. Melchers), at a final concentration of 500 Wg/ml, were used to inhibit rosette formation and were added to the cells at the same time as the IgG coated ORBC .
Results
FcR and C-Receptors on Normal Lymphocyte Populations . Table I Table I . FcR on Activated T Cells . 40% of activated T cells from the spleen of irradiated F, mice (ATC-spleen) given H-2 or M-locus incompatible thymus cells 4 or 5 days previously formed Fc-rosettes (Table II) . More than 90% of the ATCspleen suspensions were viable after dead cell removal ; in addition >95% of these viable cells were lysed by anti-Thy 1 .2 serum plus C . Only 1-2% of ATCspleen, however, formed EAC-rosettes (Table II) .
In another series of experiments, nylon-wool-purified T cells (Ig+ 0%, Thy 1 .2+ > 99%) derived from lymph nodes were used to prepare ATC-spleen. As seen in Table III lymph node T cells, though FcR-negative before transfer (Table I) , developed FcR after in vivo activation by H-2-or M-locus differences . In both populations, 80-90% of the Fc-rosette-forming cells were blasts . Again, the number of EAC-rosettes was negligible .
95% of the M-locus-activated ATC-spleen (M-ATC-spleen) were lysed by antiThy 1 .2 serum and C . This serum lysed 100% of H-2-ATC-spleen (Fig . 1) ; by indirect immunofluorescence, 100% of these cells expressed Thy 1 .2, and 0% were Ig+ . Fig . 1 also shows that virtually all of the isolated H-2-ATC-spleen were donor-derived, i .e. 100% of the cells were killed with C57BL anti-CBA serum, whereas only background lysis was obtained with CBA anti-C57BL (antihost) serum ; the latter killed almost 100% of normal C57BL or (CBA x C57BL)F, cells .
Inhibition ofATC FcR by Purified Myeloma Proteins . The degree of inhibition of Fc-rosette formation by purified myeloma proteins is shown in Table IV . At the protein concentration used, only MOPC 141 (IgG2b) gave strong inhibition of rosette formation, using both M-ATC-spleen and H-2-ATC-spleen . No inhibition was observed with either cellular or secreted IgM from MOPC 104 .
Failure to Detect FcR on T .TDL . Almost 100% of T.TDL are Thy 1 .2 positive and of donor origin (Fig . 2) . In direct contrast to ATC-spleen, T.TDL contained 11 Mean t SE . no Fc-rosette-forming cells (Table V) , using ORBC coated with MIgG, RIgG, MIgM, or RIgM . EAC-(MIgM, RIgM, MC) rosettes were also absent .
No rosette-forming cells were detected when T.TDL were incubated with ORBC AT 37°C instead of at 4°C or if the T.TDL were preincubated at 37°C for 6-8 h in RPMI 199 and 10% FCS (5% CO2 incubator) .
A high proportion of T.TDL raised against H-2 differences (H-2-T .TDL) express surface Ig (Table V) most of which appears to be specific IgM antibody of donor B-cell origin (19 could have contributed to the failure of T. TDL to form Fc-rosettes, tests 'were carried out with two populations of T.TDL which lack surface Ig. These populations were (a) H-2-T .TDL prepared from T cells depleted of B cells before injection and (b) T.TDL raised between strains differing by determinants recognized by T cells but not B cells, i.e., M-locus determinants (M-T.TDL) . As shown in Table V , neither of these populations formed Fc-rosettes .
Previous work' showed that when T.TDL were reexposed to the activating antigens, i.e . by transfer to secondary hosts syngeneic with the primary hosts, the cells synthesized DNA in the spleens of their new hosts. Irradiated Fi mice receiving H-2-T .TDL had twice as many Fc-rosette-forming cells per spleen compared to unreconstituted X-irradiated mice (Table VI) . This would suggest that at least a proportion of T.TDL had the potential to express FeR after reactivation.
Ia-Antigens on ATC . Ia-antigens can easily be demonstrated on B cells
where they are closely associated with the B cell FcR (20) . In agreement with other authors (10) , Is antigens were demonstrated in a microcytotoxicity assay with ATH anti-ATL serum and C on a low number of thymus cells and a proportion of cortisone resistant and lymph node T cells (Fig. 3) . Fig. 1 and 4 show that la-antigens were also expressed on H-2-activated T cells (ATC-spleen and H-2-T .TDL). As ATH anti-ATL serum is specific for Iak determinants, i.e. determinants present on cells from H-2 k (e.g. CBA/J) strains but not on H-25 (e.g. SJL/J) strains, the antiserum lysed only H-2-ATC-spleen of CBA/J origin (Fig. 1) , but not of SJL/J origin (Fig. 4) . Virtually all H-2-ATC of when treated with high concentrations of antierythrocyte antibody (23) . Antibody-coated ORBC should therefore present a greater density of Fc-determinants to FcR-bearing cells. Thus, antibody-coated ORBC are sensitive indicator cells for detecting FcR. Furthermore, preference for the ORBC rosetting technique is based on the ease with which a fractionation of rosetting and nonrosetting cells can eventually be accomplished . FcR were detected on 20% of normal lymph node cells, but not on normal cortisone-resistant thymus cells or on lymph node cells depleted of Ig-bearing cells. These data are consistent with the evidence of other workers that the majority of B lymphocytes, but not T lymphocytes, express easily detectable FcR (1) .
Of the various T-cell populations studied, FcR were detected only on ATCspleen . As with B cells, rosette formation with ATC-spleen was demonstrable with EA(IgG), but not with EA(IgM); furthermore, as observed by other workers (2), rosette formation was blocked in the presence of myeloma IgG (IgG2b) but not with IgM. In contrast to B cells, ATC-spleen did not express detectable Creceptors. Significantly, FcR were not detected on other activated T-cell populations, i.e., T.TDL, Con A blasts, or PHA blasts . H-2-T.TDL derived from normal thymus or lymph node cells carry surface IgM which appears to be donor-B-cellderived alloantibody (19) . It was possible, therefore, that the failure to detect FcR on T.TDL was the result of blockade by passively absorbed surface Ig. This seemed unlikely, however, since FcR were also not detectable on two populations of T.TDL which lacked surface Ig: (a) H-2-T.TDL derived from T-cell populations depleted of B cells and (b) T.TDL raised against M-locus determinants, i.e ., determinants which stimulate T cells but do not induce alloantibody formation by B cells (22) (Table VII) .
Inasmuch as the production of T.TDL is associated with extensive T-cell proliferation in the lymphoid organs, particularly the spleen (23) , it is probable that T.TDL are largely derived from ATC-spleen . The present data might suggest, therefore, that in response to major transplantation antigens or Mlocus determinants in vivo, T cells change from being FcR-negative at the time of injection to FcR-positive during proliferation in the spleen and then revert to an FcR-negative state during migration into the central lymph. Can one con- (a) It has been mentioned that most T.TDL are probably derived from ATCspleen . There is no evidence, however, that the progenitors in the spleen are FcR-positive . Since the proportion of FcR-positive cells in ATC-spleen did not exceed 50%, it is equally possible that T.TDL were derived from the FcRnegative population. It is nevertheless of interest that T .TDL appeared to express FcR when they were restimulated upon secondary transfer (Table VI) .
(b) Since FcR were not demonstrable on T cells stimulated with PHA or Con A, the expression of FcR did not appear to be simply a nonspecific event upon blast transformation .
(c) The rosetting technique is only one of several techniques available for detecting FeR . In this respect it is reported that FcR can be demonstrated with heat-aggregated Ig on normal thymus cells (2) . It could be argued, therefore, that the failure to find FcR on T.TDL reflected inadequacies in the sensitivity or the specificity of the technique employed. On this point it may be mentioned that in a separate study, Basten et al. 4 have been unable to demonstrate FcR on T.TDL with a variety of techniques, viz . rosetting with SRBC, heat-aggregated human gamma globulin, and radiolabeled immune complexes. Despite these and our negative findings, Ig can be detected on a large proportion of H-2-T .TDL (Table V and (19)), but not on H-2-ATC-spleen (Table II) . These findings will be discussed in detail elsewhere.s
In view of the above points it is equally possible that there is no clear-cut division of T cells into FcR-positive and FcR-negative cells, but that at certain stages of differentiation there is either a quantitative or qualitative change in the expression of these receptors .
No evidence was found that IgM was cytophilic for either T cells or B cells. Nevertheless, uptake of IgM has been demonstrated on T cells by a variety of techniques and in several species, e .g. rats (24) , chickens (25) , and man (26) . It has been shown that several anti-Ia sera contain strong activity against Ctype viruses.s It is also known that such viruses can be activated by graft-vs .-host reactions (27) . It was conceivable, therefore, that the lytic activity of the anti-Ia serum on ATC (i .e ., cells proliferating as the result of a graft vs . host reaction) was directed against viral antigens . The fact that the antiserum used (ATH anti-ATL (anti-Ia')) lysed CBA/J ATC (Ia') but not SJL/J ATC (Ia') makes this possibility unlikely. Experiments are currently in progress to exclude the possibility that the la-antigens were passively absorbed .
In conclusion, the distribution of Ia-antigens, FcR, and Ig on the various Tcell populations studied, as shown in Table VII , does not provide any evidence for a discernible interrelationship between these three cell surface structures . For Ia-antigens and FcR, however, biochemical studies on the molecular level are necessary to determine an association of these cell surface components, especially when they are present on the membrane of the same cell like on H-2-ATC-spleen .
Summary
Using antibody coated bovine erythrocytes we were unable to demonstrate Fcreceptors on either thymus cells or T cells prepared from lymph node cell suspensions by anti-Ig column filtration . However, if parental thymus or lymh node T cells were transferred to X-irradiated F, hybrids, activated donor T cells recovered from the recipient's spleen (ATC-spleen) were shown to express Fcreceptors. Fc-receptors were also demonstrable on ATC-spleen prepared between strain combinations differing at the M-locus. In marked contrast, Fcreceptors were not detected on ATC recovered from thoracic duct lymph (T .TDL) . This applied to (a) H-2-activated T.TDL derived from normal thymus cells, (b) H-2-activated T.TDL derived from thymus cells depleted of B cells, and (c) M-locus-activated T.TDL . Of these three populations, surface Ig (of B cell origin) was detected on a large proportion of the first but not on the second and third populations . Thus, the failure to detect Fc-receptors on any of these populations could not be attributed to blocking by adsorbed surface Ig .
In addition, various T-cell populations were examined by a microcytotoxicity assay for the presence of cell surface Ia-antigens. 5-10% of the thymus cells, 20-30% of cortisone-resistant thymus cells, 60-70% of lymph node cells, and 60-80% of ATC-spleen and T.TDL showed Ia . 
